Epidemiological Assessment of Oral and Oropharyngeal Squamous Cell Carcinomas Before, During, and After the COVID-19 Pandemic, 2018–2024
Neck dissection was independently associated with the pandemic/post‑pandemic period (adjusted OR 1.87, 95% CI 1.06–3.29; p = 0.030).
The finding indicates that the COVID‑19 pandemic sustained or exacerbated delays and changes in head‑and‑neck cancer management, emphasizing the need for uninterrupted onco‑surveillance and timely referral. The study provides event‑level data supporting policy initiatives to protect cancer care during public‑health crises.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
- Anti‑PD‑1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double‑blind phase 3 study
- Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
- Nasopharyngeal Cancer
- Hierarchical dynamic model for risk‑stratified screening of nasopharyngeal carcinoma